Clinical Trials in Chicago

Showing 2141-2160 of 17,609 trials

Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease

NCT06919081

In this phase II randomized double-masked clinical trials, subjects with non-resolving corneal epithelial disease/defect (i.e., refractory to standard treatments for at least two weeks) will receive 8 weeks treatment of topical mesenchymal stem cell secretome or vehicle, with continued follow-up for up to Day 70.

Persistent Corneal Epithelial DefectCorneal Epithelial Disorders

University of Illinois at Chicago24 participantsStarted Aug 2025

Chicago, Illinois, United States

Active Not RecruitingPhase 2/32.2 miles

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

NCT05818553

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

SCN2A EncephalopathySCN8A Encephalopathy

Praxis Precision Medicines77 participantsStarted Aug 2023

Atlanta, Georgia, United States • Chicago, Illinois, United States • Minneapolis, Minnesota, United States +5 more locations

COMPLETEDPhase 2/32.2 miles

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

NCT05721573

A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Subjects with Inclusion Body Myositis

Inclusion Body Myositis

Abcuro, Inc.272 participantsStarted Feb 2023

Phoenix, Arizona, United States • Irvine, California, United States • Los Angeles, California, United States +42 more locations

Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Find Trials by Condition in Chicago

Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects

Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM

Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

Clinical Study of the Treovance Stent-Graft for Patients With Abdominal Aortic Aneurysms

The Thrive Study: Improving Multimodal Physical Function in Adults With Heterogenous Chronic Pain

More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents

TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients

Initiating Early Control of Migraine Pain and Associated Symptoms

Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD

A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis

Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms

Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)

Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors

Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD

Early Onset Colorectal Cancer Detection